Classement en actions
#16184
Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived... Cuorips Inc. specializes in the comprehensive lifecycle of iPS cell-derived cardiomyocyte sheets, undertaking their research, development, production, commercialization, and distribution. The firm's portfolio extends to include cellular, tissue-based, and cell processing products. Furthermore, it offers contract development and manufacturing services, alongside expert consulting. The company, which was incorporated in 2017 and is based in Tokyo, Japan, previously operated under the name Cuore Inc. before adopting Cuorips Inc. in June 2017.
Capitalisation boursière
$307.63M
Changement (1 jour)
-1.55%
Changement (1 an)
-26.02%
Échange Cuorips Inc. (4894)
Le prix 4894 avec la capitalisation boursière de B
Capitalisation boursière de Cuorips Inc.(4894)
Capitalisation boursière: $307.63M
En September 2026, Cuorips Inc. a une capitalisation boursière de $307.63M. Cela fait de Cuorips Inc. la 16184th entreprise la plus valorisée au monde selon nos données. La capitalisation boursière, souvent appelée market cap, correspond à la valeur totale des actions en circulation d’une entreprise cotée en bourse, et est couramment utilisée pour évaluer sa valeur.
Historique de la capitalisation boursière de Cuorips Inc. du 2023 au 2026
4894 par rapport au top 5 des plus populaires stocks
| Prix pour 4894 |
|
L’actif B |
La capitalisation boursière de B |
Résultats |
|
|
|
|
$5.260T
|
+1,709,644.95%
|
|
|
|
|
$4.779T
|
+1,553,260.51%
|
|
|
|
|
$4.017T
|
+1,305,624.79%
|
|
|
|
|
$3.719T
|
+1,208,938.52%
|
|
|
|
|
$2.734T
|
+888,721.19%
|
